Related Experiment Video
Updated: May 24, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Angio-oedema due to hereditary C1 inhibitor deficiency in children
1Servicio de Alergia, Hospital La Paz Health Research Institute (IdiPaz), Biomedical Research Network on Rare diseases-U754 (CIBERER), Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.
Insights
Hereditary angio-oedema due to C1 inhibitor deficiency (HAE-C1-INH) is a rare genetic disorder causing swelling attacks. Early diagnosis and treatment in children can significantly reduce the disease
Area of Science:
- Pediatric Allergy and Immunology
- Rare Genetic Disorders
- Immunology
Background:
- Hereditary angio-oedema due to C1 inhibitor deficiency (HAE-C1-INH) is a rare inherited disorder.
- Characterized by recurrent swelling episodes (cutaneous, abdominal, laryngeal).
- Onset typically in childhood/adolescence, with earlier onset linked to increased severity.
Purpose of the Study:
- To review the clinical presentation and management of HAE-C1-INH in children.
- To highlight challenges in pediatric diagnosis.
- To discuss available and emerging treatments for pediatric HAE-C1-INH.
Main Methods:
- Literature review of pediatric HAE-C1-INH cases and treatment data.
- Analysis of diagnostic delays and challenges.
- Evaluation of current therapeutic options and their pediatric evidence.
Main Results:
- HAE-C1-INH in children causes significant physical, psychological, and academic impairment.
- Diagnostic delays are common due to varied symptoms mimicking gastrointestinal issues.
- Pediatric efficacy and safety data exist for some newer HAE-C1-INH treatments.
Conclusions:
- Early diagnosis of HAE-C1-INH in children is crucial.
- Appropriate and timely therapy can mitigate the disease burden in pediatric patients.
- Ongoing research and data collection are needed for pediatric-specific treatment guidelines.
Abstract:
Hereditary angio-oedema due to C1 inhibitor deficiency (HAE-C1-INH) is a rare inherited disorder characterised by recurring and debilitating episodes of cutaneous swelling and abdominal pain and less frequent episodes of laryngeal oedema. Symptom onset is usually in childhood and early adolescence, with earlier disease onset associated with greater disease severity. Although HAE-C1-INH attacks are generally less frequent and less severe in children than in adults, they can cause significant physical and psychological impairment and affect advancement in school. There are often significant delays in the diagnosis of HAE-C1-INH due to its variable clinical presentation and because abdominal symptoms can often mimic other common paediatric gastrointestinal disorders. In recent years, several disease-specific agents have become available for the acute and prophylactic treatment of HAE-C1-INH. Although these treatments have not been evaluated rigorously in controlled clinical trials in children with HAE-C1-INH, paediatric data on efficacy and safety are available for some agents. Early diagnosis and initiation of appropriate therapy in children with HAE-C1-INH can help reduce the burden of this illness in the paediatric population.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Nephrotic Syndrome I : Introduction
Cytotoxic Edema: Pathophysiology
Cerebral Edema ll: Pathophysiology
Glaucoma: Overview

